5th Circuit Halts Mail Delivery of Abortion Pill, Sets Up Supreme Court Clash

TL;DR: The 5th Circuit Court of Appeals issued a temporary order blocking nationwide mail delivery of mifepristone, requiring patients to get the abortion pill in person. The move sets up a likely Supreme Court battle as the drug’s distributor seeks a one‑week pause and Louisiana’s attorney general praises the ruling.

Context: In March 2025, Louisiana sued the FDA over its approval of mifepristone for mail distribution, arguing the drug poses risks. A three‑judge panel of the 5th Circuit, dominated by Republican appointees, granted a temporary stay that overturns a lower court decision allowing mail delivery while the FDA reviews its rules. The order applies to all states, forcing anyone seeking a medication abortion to obtain mifepristone from a clinic or pharmacy rather than through mail order. This marks the first nationwide restriction on the drug since the FDA first approved it in 2000.

Key Facts: The 5th Circuit’s temporary order stops the mailing of mifepristone across the United States. Danco Laboratories, one of the two U.S. distributors of the drug, asked the court for a one‑week pause of the order while it prepares to seek emergency relief from the Supreme Court. Louisiana Attorney General Liz Murrill welcomed the decision, calling it a victory and claiming the Biden administration caused thousands of fetal deaths through mail‑order abortion pills.

What It Means: The ruling ends a widely used telehealth option for medication abortion, which accounted for over half of abortions in the U.S. before the decision. Patients in states with limited clinic access may face longer travel times and higher costs, while providers must adjust dispensing practices. Legal experts expect the case to reach the Supreme Court quickly, where the justices will weigh whether the appellate court overstepped its authority and whether the FDA’s mail‑order policy can stand. Watch next for whether the Supreme Court grants Danco’s requested stay, how the Biden administration responds, and whether other circuits issue conflicting rulings that could prompt a national uniform rule.